Cable Hill Partners, LLC Moderna, Inc. Transaction History

Cable Hill Partners, LLC

$964 Million
Q3 2024

A detailed history of Cable Hill Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cable Hill Partners, LLC holds 3,112 shares of MRNA stock, worth $114,677. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,112

Previous 2,981 4.39%

Holding current value

$114,677

Previous $353,000 41.36%

% of portfolio

0.02%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$63.64 - $125.14 $8,336 - $16,393	131 Added 4.39%	3,112 $207,000
Q2 2024 Jul 22, 2024	BUY	$101.21 - $166.61 $301,707 - $496,664	2,981 New	2,981 $353,000
Q3 2023 Oct 27, 2023	SELL	$96.41 - $126.61 $22,174 - $29,120	-230 Reduced 8.46%	2,490 $257,000
Q2 2023 Jul 19, 2023	SELL	$118.5 - $160.53 $17,656 - $23,918	-149 Reduced 5.19%	2,720 $330,000
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $32,151 - $46,693	-237 Reduced 7.63%	2,869 $440,000
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $8,286 - $14,702	70 Added 2.31%	3,106 $557,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $14,758 - $24,272	125 Added 4.29%	3,036 $359,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $57,627 - $86,882	492 Added 20.34%	2,911 $416,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $27,188 - $50,535	215 Added 9.75%	2,419 $417,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $451 - $737	-2 Reduced 0.09%	2,204 $560,000
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $44,380 - $96,894	-200 Reduced 8.31%	2,206 $849,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $28,060 - $50,755	-216 Reduced 8.24%	2,406 $565,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $32,317 - $55,050	296 Added 12.73%	2,622 $343,000
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $152,911 - $395,094	2,326 New	2,326 $243,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.

Account

Cable Hill Partners, LLC Moderna, Inc. Transaction History